Centiva Capital’s BioLife Solutions BLFS Stock Holding History

Centiva Capital’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,283	Closed	-$281K	–	1554
2025 Q1	$281K	Buy	+12,283	New	+$323K	0.01%	1118

Other funds holding BLFS

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

Centiva Capital's BLFS Position: Q2 2025 in Review

Centiva Capital sold out of BioLife Solutions (BLFS) in Q2 2025, closing a stake of 12,283 shares — an estimated $281K sold.

Centiva Capital first reported a position in BLFS in Q1 2025 and held it in 1 quarter. The position peaked at $281K in Q1 2025. 194 funds tracked by Wall St. Rank hold BLFS as of Q2 2025.

Centiva Capital reported no remaining BioLife Solutions position as of Q2 2025 after selling out during the quarter.
Centiva Capital sold 12,283 BioLife Solutions shares in Q2 2025, an estimated $281K.
Centiva Capital first reported a position in BioLife Solutions in Q1 2025 and held it in 1 quarter.
Centiva Capital's BioLife Solutions position peaked at $281K in Q1 2025.
194 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2025.

Based on Centiva Capital's 13F filing for Q2 2025, filed 13 Aug 2025.